"Nucleus Network runs early-stage clinical trials for some of the world’s leading pharmaceutical companies in Brisbane. We are always looking for healthy volunteers from all walks of life. You can make a difference by assisting with the research of new medicines and be reimbursed up to $360 per day for your valuable time."

During the past decade, Nucleus Network conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nucleus Network" #1 sponsor was "Atridia Pty Ltd." with 2 trials, followed by "Acrux DDS Pty Ltd" with 1 trials sponsored, "Alios Biopharma Inc." with 1 trials sponsored, "Alvotech Swiss AG" with 1 trials sponsored and "Avidia" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nucleus Network" #1 collaborator was "Avance Clinical Pty Ltd." with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Vertex Pharmaceuticals Incorporated" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Nucleus Network" are "Asthma" (2 trials), "Psoriasis" (2 trials), "Androgenetic Alopecia" (1 trials), "COVID-19 Respiratory Infection" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Nucleus Network" in a lesser frequency.

Most popular intervention types in "Nucleus Network" are "Drug" (8 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "ALS-002158" (1 trials), "BFI-751" (1 trials), "C326, IL-6 Inhibitory Avimer protein" (1 trials) and "EU-STELARA®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nucleus Network" are 8 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Nucleus Network". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Nucleus Network, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Nucleus Network, 8 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".